BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chupradit K, Moonmuang S, Nangola S, Kitidee K, Yasamut U, Mougel M, Tayapiwatana C. Current Peptide and Protein Candidates Challenging HIV Therapy beyond the Vaccine Era. Viruses 2017;9:E281. [PMID: 28961190 DOI: 10.3390/v9100281] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Moonmuang S, Maniratanachote R, Chetprayoon P, Sornsuwan K, Thongkum W, Chupradit K, Tayapiwatana C. Specific Interaction of DARPin with HIV-1 CANTD Disturbs the Distribution of Gag, RNA Packaging, and Tetraspanin Remodelling in the Membrane. Viruses 2022;14:824. [PMID: 35458554 DOI: 10.3390/v14040824] [Reference Citation Analysis]
2 Kleinman AJ, Pandrea I, Apetrei C. So Pathogenic or So What?-A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research. Viruses 2022;14:135. [PMID: 35062339 DOI: 10.3390/v14010135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sornsuwan K, Thongkhum W, Pamonsupornwichit T, Carraway TS, Soponpong S, Sakkhachornphop S, Tayapiwatana C, Yasamut U. Performance of Affinity-Improved DARPin Targeting HIV Capsid Domain in Interference of Viral Progeny Production. Biomolecules 2021;11:1437. [PMID: 34680070 DOI: 10.3390/biom11101437] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Minooei F, Fried JR, Fuqua JL, Palmer KE, Steinbach-Rankins JM. In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection. Int J Nanomedicine 2021;16:1189-206. [PMID: 33623382 DOI: 10.2147/IJN.S287310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Wani SS, Dar PA, Zargar SM, Dar TA. Therapeutic Potential of Medicinal Plant Proteins: Present Status and Future Perspectives. Curr Protein Pept Sci 2020;21:443-87. [PMID: 31746291 DOI: 10.2174/1389203720666191119095624] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ghiasifar Z, Salehabadi H, Adibpour N, Alipour E, Kobarfard F, Shoushizadeh MR. Synthesis of Biuret Derivatives as Potential HIV ‐1 Protease Inhibitors Using ( LDHs‐g‐HMDI‐Citric Acid), as a Green Recyclable Catalyst. Bull Korean Chem Soc 2021;42:48-59. [DOI: 10.1002/bkcs.12152] [Reference Citation Analysis]
7 Feng LS, Zheng MJ, Zhao F, Liu D. 1,2,3-Triazole hybrids with anti-HIV-1 activity. Arch Pharm (Weinheim) 2021;354:e2000163. [PMID: 32960467 DOI: 10.1002/ardp.202000163] [Cited by in Crossref: 8] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
8 Eid J, Mougel M, Socol M. Advances in Continuous Microfluidics-Based Technologies for the Study of HIV Infection. Viruses 2020;12:E982. [PMID: 32899657 DOI: 10.3390/v12090982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Larijani MS, Ramezani A, Sadat SM. Updated Studies on the Development of HIV Therapeutic Vaccine. Curr HIV Res 2019;17:75-84. [PMID: 31210114 DOI: 10.2174/1570162X17666190618160608] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
10 Jackson JW, Hancock TJ, Dogra P, Patel R, Arav-Boger R, Williams AD, Kennel SJ, Wall JS, Sparer TE. Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of In Vitro Screenings. mSphere 2019;4:e00586-18. [PMID: 30760613 DOI: 10.1128/mSphere.00586-18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sakkhachornphop S, Hadpech S, Wisitponchai T, Panto C, Kantamala D, Utaipat U, Praparattanapan J, Kotarathitithum W, Taejaroenkul S, Yasamut U, Chupradit K, Moonmuang S, Sanghiran Lee V, Suparatpinyo K, Tayapiwatana C. Broad-Spectrum Antiviral Activity of an Ankyrin Repeat Protein on Viral Assembly against Chimeric NL4-3 Viruses Carrying Gag/PR Derived from Circulating Strains among Northern Thai Patients. Viruses 2018;10:E625. [PMID: 30428529 DOI: 10.3390/v10110625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
12 Moonmuang S, Saoin S, Chupradit K, Sakkhachornphop S, Israsena N, Rungsiwiwut R, Tayapiwatana C. Modulated expression of the HIV-1 2LTR zinc finger efficiently interferes with the HIV integration process. Biosci Rep 2018;38:BSR20181109. [PMID: 30068696 DOI: 10.1042/BSR20181109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Awi NJ, Teow SY. Antibody-Mediated Therapy against HIV/AIDS: Where Are We Standing Now? J Pathog 2018;2018:8724549. [PMID: 29973995 DOI: 10.1155/2018/8724549] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
14 Gao Y, Kraft JC, Yu D, Ho RJY. Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy. Eur J Pharm Biopharm 2019;138:75-91. [PMID: 29678735 DOI: 10.1016/j.ejpb.2018.04.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]